Daidzein activates choline acetyltransferase from MC-IXC cells and improves drug-induced amnesia

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 1, 2006, Pages 107-111

  Heo, Ho Jin ^a,b   Suh, Young Min ^b   Kim, Mi Jeong ^b   Choi, Soo Jung ^b   Mun, Nam Shik ^c   Kim, Hye Kyung ^d   Kim, Eunki ^e   Kim, Chang Ju ^f   Cho, Hong Yon ^b   Kim, Young Jun ^b   Shin, Dong Hoon ^b  

^a Jeonnam Regional Innovation Agency   (South Korea)

^b Korea University   (South Korea)

^c Chosun University   (South Korea)

^d Hanseo University   (South Korea)

^e Inha University   (South Korea)

^f Kyung Hee University   (South Korea)

Author keywords

Amnesia; Choline acetyltransferase; Daidzein

Indexed keywords

APPROXIMATION THEORY; BIOSYNTHESIS; CELLS; DISEASE CONTROL; DRUG DOSAGE;

AMNESIA; CHOLINE ACETYLTRANSFERASE; DAIDZEIN; INJECTIONS;

ENZYMES;

CHOLINE ACETYLTRANSFERASE; DAIDZEIN; ISOFLAVONE DERIVATIVE; PLANT EXTRACT; SCOPOLAMINE;

AMNESIA; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CELL LINE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; PUERARIA; TEA;

AMNESIA; ANIMALS; BEHAVIOR, ANIMAL; CELL LINE; CHOLINE O-ACETYLTRANSFERASE; ENZYME ACTIVATION; ISOFLAVONES; MALE; MICE; MICE, INBRED ICR; PLANT EXTRACTS; PUERARIA; SCOPOLAMINE; TEA;

PUERARIA; PUERARIA MONTANA VAR. LOBATA;

EID: 31444436807     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70.107     Document Type: Article

References (28)

1. Carr, D. B., Goate, A., and Morris, J. C., Current concepts in the pathogenesis of Alzheimer's disease. Am. J. Med., 103, 3S-10S (1997).
2. Florence, B., Baptiste, F., Yves, A., and Etienne, C. H., Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease. Neurosci. Lett., 225, 169-172 (1997).
3. Oda, Y., Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol. Int., 49, 921-937 (1999).
4. Benishin, C. G., and Carroll, P. T., Acetylation of choline and homocholine by membrane bound choline-O-acetyltransferase endings. J. Neurochem., 36, 732-740 (1981).
5. Zambrzycka, A., Alberghina, M., and Strosznajder, J. B., Effects of aging and amyloid-β peptides on choline acetyltransferase activity in rat brain. Neurochem. Res., 27, 277-281 (2002).
6. Heo, H. J., Park, Y. J., Suh, Y. M., Choi, S. J., Kim, M. J., Cho, H. Y., Chang, Y. J., Hong, B. S., Kim, H. K., Kim, E. K., Kim, C. J., Kim, B. G., and Shin, D. H., Effects of oleamide on choline acetyltransferase and cognitive activities. Biosci. Biotechnol. Biochem., 67, 1284-1291 (2003).
7. Fonnum, F., A rapid radiometric method for the determination of choline acetyltransferase. J. Neurochem., 24, 407-409 (1975).
8. Benzi, G., and Morreti, A., Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease? Eur. J. Pharmacol., 346, 1-13 (1998).
9. Kopelman, M. D., and Corn, T. H., Cholinergic blockade as a model of cholinergic depletion. Brain, 111, 1079-1110 (1988).
10. Sarter, M., Bodewitz, G., and Stephens, D. N., Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and beta-carbolines. Psychopharmacology, 94, 491-495 (1988).
11. Peter, S. G. H., Alzheimer's disease. Neurobiol. Dis., 7, 546-548 (2000).
12. Khalid, I., and Inge, G. I., Alzheimer disease is multi-factorial and heterogeneous. Neurobiol. Aging, 21, 901-902 (2000).
13. Dave, M., The intersection of alzheimer's disease and typical aging. Neurobiol. Aging, 22, 159-160 (2001).
14. David, G. M., and Howard, F., Causes of alzheimer's disease. CMAJ., 162, 65-72 (2000).
15. Collerton, D., Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience, 19, 1-28 (1986).
16. Park, C. H., Kim, S. H., Choi, W., Lee, Y. J., Kim, J. S., Kang, S. S., and Suh, Y. H., Novel acetylcholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa. Planta Med., 62, 405-409 (1996).
17. Emi, S., and Masayoshi, Y., Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells. Biochem. Pharmacol., 59, 471-475 (2000).
18. Park, K. Y., Jung, G. O., Choi, J. W., Lee, K. T., and Park, H. J., Potent antimutagenics and the anti-lipid peroxidative effect of kaikasaponin III and tectorigenin from the flower of Pueraria thunbergiana. Arch. Pharm. Res., 25, 320-324 (2002).
19. Pattie, S. G., and James, W., Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci., 18, 347-358 (2000).
20. Waring, S. C., Rocca, W. A., Peterson, R. C., and Kokmen, E., Postmenopausal estrogen replacement therapy and Alzheimer's disease. Neurology, 485, A79-A83 (1997).
21. Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., and Metter, E., A Prospective study of estrogen replacement therapy and the risk of developing Alzhemer's disease: the Baltimore Longitudinal Study of Aging. Neurology, 48, 1517-1521 (1997).
22. Ohkura, T., Isse, K., Akazawa, K., Hamamoto, M., Yaoi, Y., and Hagino, N., Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type. Endocr. J., 41, 361-371 (1994).
23. Paganini, H. A., Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol., 140, 256-261 (1994).
24. Luine, V., Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol., 89, 484-490 (1985).
25. Amstrong, D. M., Saper, B. C., Levey, A. I., Wainer, B. H., and Terry, R. D., Distribution of cholinergic neurons in rat brain demonstrated by the immunocytochemical localization of choline acethyltransferase. J. Comp. Neurol., 216, 53-68 (1983).
26. Luine, V. N., and Mcewen, B. S., Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area. Neuroendocrinology, 36, 475-482 (1983).
27. Muth, E., Crowley, W., and Jacobowitz, D., Effect of gonadal hormones on luteinzing hormone in plasma and on choline acetyltransferase activity and acetylcholine levels in discrete nuclei of rat brain. Neuroendocrinology, 30, 329-336 (1980).
28. Luine, V. N., Khychevskaya, R., and Mcewen, B. S., Effects of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res., 86, 293-306 (1975).